Monopar Therapeutics Inc. Share Price
MNPRMonopar Therapeutics Inc. Stock Performance
Open $90.16 | Prev. Close $87.67 | Circuit Range N/A |
Day Range $89.60 - $95.75 | Year Range $29.22 - $103.77 | Volume 9,490 |
Average Traded $93.62 |
Monopar Therapeutics Inc. Share Price Chart
About Monopar Therapeutics Inc.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Monopar Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $90.16 | $94.27 | +0.00% |
29-Jun-26 | $90.16 | $94.27 | +7.53% |
26-Jun-26 | $87.95 | $87.67 | -0.90% |
25-Jun-26 | $89.50 | $88.47 | -1.43% |
24-Jun-26 | $84.90 | $89.75 | +9.22% |
23-Jun-26 | $69.85 | $82.17 | +19.89% |
22-Jun-26 | $67.60 | $68.54 | +2.02% |
FAQs on Monopar Therapeutics Inc. Share Price
Can I buy Monopar Therapeutics Inc. shares in India?
What is the share price of Monopar Therapeutics Inc.?
What is the 5 year returns of Monopar Therapeutics Inc.?
What are the high & low stock price of Monopar Therapeutics Inc. today?
What is the 52-week high and low of Monopar Therapeutics Inc. stock?